| 1. |
Grayson PC, Ponte C, Suppiah R, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for eosinophilic granulomatosis with polyangiitis. Ann Rheum Dis, 2022, 81(3): 309-314.
|
| 2. |
嗜酸性肉芽腫性多血管炎診治多學科專家共識編寫組. 嗜酸性肉芽腫性多血管炎診治多學科專家共識(2025 年版). 中華結核和呼吸雜志, 2025, 48(5): 418-439.
|
| 3. |
Emmi G, Bettiol A, Gelain E, et al. Evidence-based guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nat Rev Rheumatol, 2023, 19(6): 378-393.
|
| 4. |
Watanabe R, Hashimoto M. Eosinophilic granulomatosis with polyangiitis: latest findings and updated treatment recommendations. J Clin Med, 2023, 12(18): 5996.
|
| 5. |
Liu S, Han L, Liu Y, et al. Clinical significance of MPO-ANCA in eosinophilic granulomatosis with polyangiitis: experience from a longitudinal Chinese cohort. Front Immunol, 2022, 13: 885198.
|
| 6. |
Zhang Z, Liu S, Guo L, et al. Clinical characteristics of peripheral neuropathy in eosinophilic granulomatosis with polyangiitis: a retrospective single-center study in China. J Immunol Res, 2020, 2020: 3530768.
|
| 7. |
Cho HJ, Yune S, Seok JM, et al. Clinical characteristics and treatment response of peripheral neuropathy in the presence of eosinophilic granulomatosis with polyangiitis (churg-strauss syndrome): experience at a single tertiary center. J Clin Neurol, 2017, 13(1): 77-83.
|
| 8. |
Yamanaka N, Takeshita Y, Sato R, et al. Acute therapeutic effects and pathophysiology of eosinophilic granulomatosis with polyangiitis neuropathy. BMJ Neurol Open, 2025, 7(1): e000938.
|
| 9. |
Bettiol A, Urban ML, Dagna L, et al. Mepolizumab for eosinophilic granulomatosis with polyangiitis: a European multicenter observational study. Arthritis Rheumatol, 2022, 74(2): 295-306.
|
| 10. |
Bettiol A, Urban ML, Padoan R, et al. Benralizumab for eosinophilic granulomatosis with polyangiitis: a retrospective, multicentre, cohort study. Lancet Rheumatol, 2023, 5(12): e707-e715.
|
| 11. |
Wechsler ME, Nair P, Terrier B, et al. Benralizumab versus mepolizumab for eosinophilic granulomatosis with polyangiitis. N Engl J Med, 2024, 390(10): 911-921.
|
| 12. |
Mattioli I, Urban ML, Padoan R, et al. Mepolizumab versus benralizumab for eosinophilic granulomatosis with polyangiitis (EGPA): a European real-life retrospective comparative study. J Autoimmun, 2025, 153: 103398.
|
| 13. |
趙本科, 王鎖彬, 楊瑩雪, 等. 累及中樞和周圍神經系統的嗜酸性肉芽腫性多血管炎一例. 腦與神經疾病雜志, 2026, 34(2): 74-79.
|
| 14. |
鄧鳴, 左輝華. 嗜酸性肉芽腫性多血管炎伴冠狀動脈痙攣 1 例. 中國心血管雜志, 2025, 30(6): 651-654.
|
